AAAAAA

   
Results: 1-8 |
Results: 8

Authors: SHOULSON I OAKES D FAHN S LANG A LANGSTON JW LEWITT P OLANOW CW PENNEY JB TANNER C KIEBURTZ K KOLLER W RODNITZKY R FINK JS GROWDON JH PAULSON G KURLAN R FRIEDMAN JH GANCHER S NUTT J RAJPUT AH BENNETT JB WOOTEN GF GOETZ C SHANNON K SUCHOWERSKY O BRIN MF BRESSMAN SB WEINER WJ SANCHEZRAMOS J JANKOVIC J TETRUD J GRIMES JD PFEIFFER R SHULTS C THAL L GAUTHIER S GOLBE LI PERLMUTTER JS MOSES H REICH SG HURTIG HI STERN M BARTER R VETEREOVERFIELD B GAUGER L MALAPIRA T DOBSON J ATAMIAN S TENNIS M COHEN JB DESCLOS G HOFFMAN E GRAEFE K BURKE C MARCUS A DENIO L HUBER S WOIKE T ZOOG K MENDELL R DUDTE K BEHR J GARDINER IF LANNON M CARTER J NORTHRUP S KANIGAN B TURK M LANDOW E SCHLICK P MISTURA K CARROLL VS THELEN JA DEMONG C WINFIELD L MOSKOWITZ C INGENITO A SHELDON C CORNELIUS L HEIBERG D DUNNE C BRADY J KIERANS C BELLESCANTLEBURY L DUFF J WEBER H SAVOINI D LEWIS P KUTNER SJ GRAY P GLAESKE C HOFMAN R PAY M SALMON D MCFAUL F AMYOT D BERGEN M MCGEEMINNICH L ODONNELL P FERRISE S SHALLOW K
Citation: I. Shoulson et al., MORTALITY IN DATATOP - A MULTICENTER TRIAL IN EARLY PARKINSONS-DISEASE, Annals of neurology, 43(3), 1998, pp. 318-325

Authors: KIEBURTZ K SHOULSON I MCDERMOTT M FAHN S LANG A OLANOW W PENNEY J WOOTEN GF KURLAN R GARDINER I PETZINGER G BRIN M DILLON S SHANNON K JAGLIN JA TROSCH R MISTURA K HARRISON M ROSTRUFFNER E TANNER C SINGER C WEINER W SHELDON C GRIMES JD GRAY P HURTIG H HAUSER R GAUGER L RAJPUT A RUDNITZKY R DOBSON J PANISSET M GAUTHIER S AMYOT D PERLMUTTER J HUBBLE J BARTER R SUCHOWERSKY O LEW M WELSH M MAREK K FUSSELL B SETHI K LIGON K RAO J RUDOLPH A CASACELI C DAY D JOHNSTON K BAKER D CHERNE C WATTS A TARIOT PN GRIGGS RC HALL WJ PETERS G CORRIGAN M BRYAN W SCHWARTZ J NEIDERT G LAI PY
Citation: K. Kieburtz et al., SAFETY AND EFFICACY OF PRAMIPEXOLE IN EARLY PARKINSON DISEASE - A RANDOMIZED DOSE-RANGING STUDY, JAMA, the journal of the American Medical Association, 278(2), 1997, pp. 125-130

Authors: BARCLAY CL HILDEBRAND K GRAY P MENDIS T MOHR E GRIMES JD
Citation: Cl. Barclay et al., RISK-FACTORS FOR THE DEVELOPMENT OF DEPRESSION IN PARKINSONS-DISEASE, Neurology, 48(3), 1997, pp. 60003-60003

Authors: SHOULSON I FAHN S OAKES D LANG A LANGSTON JW LEWITT P OLANOW CW PENNEY JB TANNER C KIEBURTZ K KOLLER W RODNITZKY R FINK JS GROWDON JH PAULSON G KURLAN R FRIEDMAN JH GANCHER S NUTT J RAJPUT AH BENNETT JB WOOTEN GF GOETZ C SHANNON K SUCHOWERSKY O BRIN MF BRESSMAN SB WEINER WJ SANCHEZRAMOS J JANKOVIC J HOEHN M TETRUD J GRIMES JD PFEIFFER R SHULTS C THAL L GAUTHIER S GOLBE LI PERLMUTTER JS MOSES H REICH SG HURTIG HI STERN M BARTER R VETEREOVERFIELD B GAUGER L MALAPIRA T DOBSON J ATAMIAN S TENNIS M COHEN JB DESCLOS G HOFFMAN E DENIO L HUBER S WOIKE T ZOOG K MENDELL R DUDTE K BEHR J GARDINER IF LANNON M CARTER J NORTHRUP S KANIGAN B TURK M LANDOW E SCHLICK P MISTURA K CARROLL VS THELEN JA DEMONG C WINFIELD L MOSKOWITZ C INGENITO A SHELDON C CORNELIUS L HEIBERG D DUNNE C BRADY J KIERANS C BELLESCANTLEBURY L DUFF J WEBER H SAVOINI D LEWIS P KUTNER SJ GRAY P GLAESKE C HOFMAN R PAY MM SALMON D MCFAUL F AMYOT D BERGEN M MCGEEMINNICH L ODONNELL P FERRISE S SHALLOW K BAKER D CASACELI C EBERLY S MCDERMOTT M NOBEL R ORME C PELUSIO RM PLUMB S RUDOLPH A RANDOLPH H SOTACK J WATTS A
Citation: I. Shoulson et al., IMPACT OF DEPRENYL AND TOCOPHEROL TREATMENT ON PARKINSONS-DISEASE IN DATATOP SUBJECTS NOT REQUIRING LEVODOPA, Annals of neurology, 39(1), 1996, pp. 29-36

Authors: SHOULSON I FAHN S OAKES D ODOROFF C LANG A LANGSTON JW LEWITT P OLANOW CW PENNEY JB TANNER C KIEBURTZ K RUDOLPH A PELUSIO RM KOLLER W OLANOW W RODNITZKY R FINK JS GROWDON JH PAULSON G KURLAN R FRIEDMAN JH GANCHER S NUTT J RAJPUT AH BENNETT JB WOOTEN GF GOETZ C SHANNON K BRIN MF BRESSMAN SB WEINER MJ SANCHEZRAMOS J JANKOVIC J HOEHN M TETRUD J GRIMES JD PFEIFFER R SHULTS C THAL L GAUTHIER S GOLBE LI PERLMUTTER JS MOSES H REICH SG HURTIG HI STERN M BARTER R VETEREOVERFIELD B GAUGER L MALAPIRA T DOBSON J ATAMIAN S TENNIS M COHEN JB DESCLOS G HOFFMAN E DENIO L HUBER S WOIKE T ZOOG K MENDELL R DUDTE K BEHR J GARDINER IF LANNON M CARTER J NORTHRUP S KANIGAN B TURK M LANDOW E SCHLICK P MISTURA K CARROLL VS THELEN JA DEMONG C WINFIELD L MOSKOWITZ C INGENITO A SHELDON C CORNELIUS L HEIBERG D DUNNE C BRADY J KIERANS C BELLESCANTLEBURY L DUFF J WEBER H SAVOINI D LEWIS P KUTNER SJ GRAY P GLAESKE C HOFMAN R PAY MM SALMON D MCFAUL F AMYOT D BERGEN M MCGEEMINNICH L ODONNELL P FERRISE S SHALLOW K
Citation: I. Shoulson et al., CEREBROSPINAL-FLUID HOMOVANILLIC-ACID IN THE DATATOP STUDY ON PARKINSONS-DISEASE, Archives of neurology, 52(3), 1995, pp. 237-245

Authors: MOHR E MENDIS T RUSK IN GRIMES JD
Citation: E. Mohr et al., NEUROTRANSMITTER REPLACEMENT THERAPY IN ALZHEIMERS-DISEASE, Journal of psychiatry & neuroscience, 19(1), 1994, pp. 17-23

Authors: MENDIS T MOHR E GEORGE A RUSK IN GRAY P GRIMES JD
Citation: T. Mendis et al., SYMPTOMATIC RELIEF FROM TREATMENT-INDUCED PSYCHOSIS IN PARKINSONS-DISEASE - AN OPEN-LABEL PILOT-STUDY WITH REMOXIPRIDE, Movement disorders, 9(2), 1994, pp. 197-200

Authors: OLANOW CW FAHN S MUENTER M KLAWANS H HURTIG H STERN M SHOULSON I KURLAN R GRIMES JD JANKOVIC J HOEHN M MARKHAM CH DUVOISIN R REINMUTH O LEONARD HA AHLSKOG E FELDMAN R HERSHEY L YAHR MD
Citation: Cw. Olanow et al., A MULTICENTER DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF PERGOLIDE AS AN ADJUNCT TO SINEMET(R) IN PARKINSONS-DISEASE, Movement disorders, 9(1), 1994, pp. 40-47
Risultati: 1-8 |